RT Journal Article
SR Electronic
T1 A general model for the demographic signatures of the transition from pandemic emergence to endemicity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.06.21260071
DO 10.1101/2021.07.06.21260071
A1 Ruiyun Li
A1 C. Jessica E. Metcalf
A1 Nils Chr. Stenseth
A1 Ottar N. Bjørnstad
YR 2021
UL http://medrxiv.org/content/early/2021/07/07/2021.07.06.21260071.abstract
AB Anticipating the medium- and long-term trajectory of pathogen emergence has acquired new urgency given the ongoing COVID-19 pandemic. For many human pathogens the burden of disease depends on age and prior exposure. Understanding the intersection between human population demography and transmission dynamics is therefore critical. Here, we develop a realistic age-structured (RAS) mathematical model that integrates demography, social mixing and immunity to establish the suite of possible scenarios of future age-incidence and burden of mortality. With respect to COVID-19, we identify a plausible transition in the age-structure of risks once the disease reaches seasonal endemism, whether assuming long-lasting or brief protective immunity, and across a range of assumptions of relative severity of primary versus subsequent reinfections. We train the model using diverse real-world demographies and age-structured social mixing patterns to bound expectations for changing age-incidence and disease burden. The mathematical framework is flexible and can help tailoring mitigation strategies countries worldwide with varying demographies and social mixing patterns.One Sentence Summary A shift of COVID-19 risks to younger age-classes in future endemic circulation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by grants from the Huck Institute of the Life Sciences, Penn State University through the Seed-funded COVID-19 Projects; Research Council of Norway through the COVID-19 Seasonality Project (Reference No. 312740). The funders of the study had no role in study design, data collection, data analysis, data interpretation or writing of the report.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNot applicable.